Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study (KAOUENN)

Concussions (also known as mild traumatic brain injury) are common in young children. In some children, they can lead to short- and long-term difficulties. However, our knowledge of the exact consequences of injuries on young children's brains and behavior is limited. These consequences may be different in children under 6, as their brains are fragile and undergoing significant developmental changes.

The aim of this study is to determine the extent to which a concussion sustained before the age of 6 years is associated with changes in young children's brain structure, function and behaviours, using a brain imaging.

In this study, the results of a group of 30 children with a concussion will be compared to those of 30 children of the same age with an orthopaedic injury to the upper or lower limbs.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Rennes, France, 35200
        • Unité des urgences médicochirurgicales CHU Rennes
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday) with mTBI.

Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday) with orthopaedic injury (simple fracture, sprain, contusion or unspecified trauma to a limb (mild))

Description

Inclusion Criteria:

  • Patient group with mild traumatic brain injury (mTBI) :

    1. Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday)
    2. Presentation to the emergency department within 48 hours post-injury
    3. Documented, unintentional traumatic event (e.g. blow, fall, etc.) resulting in non-penetrating head injury
    4. Diagnosis of mTBI (World Health Organization (WHO) paediatric diagnostic criteria)
  • Control group with orthopaedic injury:

    1. Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday)
    2. Presentation to the emergency department within 48 hours post-injury
    3. Documented, unintentional traumatic event (e.g. blow, fall, etc.) resulting in trauma to an upper or lower limb
    4. Diagnosis of simple fracture, sprain, contusion or unspecified trauma to a limb (mild).

Exclusion Criteria:

  • Diagnosis of previous TBI (any severity, any age)
  • Intentional injury,
  • Administration of sedative drugs that can alter brain function
  • Complications following injury
  • MRI contraindication,
  • Parent non-fluent in French,
  • Prematurity,
  • Diagnosis of a severe neurological, developmental, or psychiatric disorder
  • Children in foster care at the time of recruitment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with a mTBI
Children with a mTBI aged 3 to 5 years (i.e., up to 71 months and 31 days, i.e., before the 6th birthday) recruited from the paediatric emergency department of Rennes University Hospital.
A non-sedated MRI scan will be performed to assess the structure and function of the children's brains
Control with an orthopaedic injury
Children with an orthopaedic injury aged 3 to 5 years (i.e., up to 71 months and 31 days, i.e., before the 6th birthday) recruited from the paediatric emergency department of Rennes University Hospital.
A non-sedated MRI scan will be performed to assess the structure and function of the children's brains

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Persistent brain structure alterations
Time Frame: 3 months post-injury
Quantitative assessment of the brain morphometry extracted from T1-w MRI sequence
3 months post-injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Persistent brain lesions - Volume
Time Frame: 3 months post-injury
Volume of brain lesions measured with susceptibility MRI
3 months post-injury
Persistent brain lesions - Number
Time Frame: 3 months post-injury
Number brain lesions measured with susceptibility MRI
3 months post-injury
Cerebral blood flow alteration
Time Frame: 3 months post-injury
Cerebral blood flow quantified by arterial spin labelling perfusion MRI (ASL)
3 months post-injury
Functional integrity of brain networks
Time Frame: 3 months post-injury
Functional connectivity (i.e., correlation between the activation of brain regions) measured by resting-state functional MRI
3 months post-injury
Structural integrity of brain networks
Time Frame: 3 months post-injury
White matter micro-structure measured by diffusion MRI
3 months post-injury

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute and persistent post-concussive symptoms
Time Frame: Through study completion, an average of 3 months
Assessment of post-concussive symptoms using the REACTIONS questionnaire
Through study completion, an average of 3 months
Persistent behavioural difficulties
Time Frame: 3 months post-injury
Assessment of behaviour using the Strengths and Difficulties Questionnaire
3 months post-injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fanny DÉGEILH, PhD, Institut National de la Santé Et de la Recherche Médicale, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 2, 2023

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

February 27, 2025

Study Registration Dates

First Submitted

July 7, 2023

First Submitted That Met QC Criteria

August 28, 2023

First Posted (Actual)

September 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on TBI (Traumatic Brain Injury)

Clinical Trials on IRM exam

3
Subscribe